The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach

M. Mac Aogáin (Singapore, Singapore), C. Zhao (Singapore, Singapore), R. Purbojati (Singapore, Singapore), D. Drautz-Moses (Singapore, Singapore), A. Lim Yick Hou (Singapore, Singapore), T. Low (Singapore, Singapore), T. Ong (Singapore, Singapore), M. Koh (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), L. Yang (Singapore, Singapore), S. Schuster (Singapore, Singapore), S. Chotirmall (Singapore, Singapore)

Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Session: The microbiome: novel data across respiratory diseases
Session type: Oral Presentation
Number: 5141
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mac Aogáin (Singapore, Singapore), C. Zhao (Singapore, Singapore), R. Purbojati (Singapore, Singapore), D. Drautz-Moses (Singapore, Singapore), A. Lim Yick Hou (Singapore, Singapore), T. Low (Singapore, Singapore), T. Ong (Singapore, Singapore), M. Koh (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), L. Yang (Singapore, Singapore), S. Schuster (Singapore, Singapore), S. Chotirmall (Singapore, Singapore). The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach. 5141

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
From culturomics to metagenomics: the mycobiome in chronic respiratory diseases
Source: Eur Respir Monogr 2019; 83: 88-118
Year: 2019


Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease
Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD
Year: 2011


Omics in population studies: a molecular epidemiology perspective in chronic airway disease
Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Year: 2014



The microbiome in chronic respiratory diseases
Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice?
Year: 2017


The airway mycobiome and its relevance to respiratory disease
Source: International Congress 2019 – PG16 Assessment and analysis of the lung microbiome
Year: 2019


Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011



Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005

Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005



Host–microbe interactions in distal airways: relevance to chronic airway diseases
Source: Eur Respir Rev 2015; 24: 78-91
Year: 2015



Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018


Mucosal cryobiopsies: A novel method for studying obstructive airways disease?
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017



The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012

The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019


The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012


Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development?
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


What are the common biological mechanisms that lead to obstructive airway disease?
Source: International Congress 2016 – Early life origins of asthma and COPD
Year: 2016